ANTIBODY RESPONSE TO HIGH-DOSE TRIVALENT VS STANDARD-DOSE QUADRIVALENT INFLUENZA VACCINE IN PATIENTS WITH HIGH-RISK CARDIOVASCULAR DISEASE: THE INVESTED TRIAL

被引：0
|
作者：
Peikert, Alexander [1 ]
Claggett, Brian [1 ]
Udell, Jacob A. [1 ]
Joseph, Jacob [1 ]
Hegde, Sheila M. [1 ]
Mao, Lu [1 ]
Wang, Tuo [1 ]
Havighurst, Thomas [1 ]
Farkouh, Micheal [1 ]
Bhatt, Deepak L. [1 ]
Tattersall, Matthew C. [1 ]
Cooper, Lawton S. [1 ]
Solomon, Scott D. [1 ]
Vardeny, Orly [1 ]
机构：
[1] Brigham & Womens Hosp, Harvard Med Sch, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1473-223
引用
收藏
页码：2003 / 2003
页数：1
相关论文
共 50 条
  • [21] Reply letter to "Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial"
    Hadigal, Sanjay
    Colombo, Laura
    Haughie, Scott
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [22] Standard-Dose vs High-Dose Multivitamin Supplements for HIV
    Padayatty, Sebastian J.
    Levine, Mark
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (06): : 545 - 546
  • [23] High-Dose vs Standard-Dose Influenza fl uenza Vaccine in Chronic Kidney Disease A Secondary Analysis of DANFLU-1
    Bartholdy, Katja Vu
    Johansen, Niklas Dyrby
    Janstrup, Kira Hyldekaer
    Modin, Daniel
    Nealon, Joshua
    Samson, Sandrine
    Loiacono, Matthew M.
    Harris, Rebecca
    Larsen, Carsten Schade
    Jensen, Anne Marie Reimer
    Landler, Nino Emanuel
    Claggett, Brian L.
    Solomon, Scott D.
    Landray, Martin J.
    Gislason, Gunnar H.
    Hansen, Ditte
    Kober, Lars
    Sivapalan, Pradeesh
    Vestergaard, Lasse Skafte
    Jensen, Jens Ulrik Staehr
    Biering-Sorensen, Tor
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (12) : 1144 - 1148
  • [24] Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection
    Hakim, Hana
    Allison, Kim J.
    Van de Velde, Lee-Ann
    Tang, Li
    Sun, Yilun
    Flynn, Patricia M.
    McCullers, Jonathan A.
    VACCINE, 2016, 34 (27) : 3141 - 3148
  • [25] A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
    Natori, Yoichiro
    Shiotsuka, Mika
    Slomovic, Jaclyn
    Hoschler, Katie
    Ferreira, Victor
    Ashton, Peter
    Rotstein, Coleman
    Lilly, Les
    Schiff, Jeffrey
    Singer, Lianne
    Humar, Atul
    Kumar, Deepali
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (11) : 1698 - 1704
  • [26] Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccine Among Patients Receiving Maintenance Hemodialysis
    Butler, Anne M.
    Layton, J. Bradley
    Dharnidharka, Vikas R.
    Sahrmann, John M.
    Seamans, Marissa J.
    Weber, David J.
    McGrath, Leah J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (01) : 72 - 83
  • [27] Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients
    Baluch, A.
    Humar, A.
    Eurich, D.
    Egli, A.
    Liacini, A.
    Hoschler, K.
    Campbell, P.
    Berka, N.
    Urschel, S.
    Wilson, L.
    Kumar, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (04) : 1026 - 1033
  • [28] High-dose trivalent influenza vaccine: safety and immunogenicity
    Ortiz de Lejarazu, Raul
    Martinon Torres, Federico
    Gil de Miguel, Angel
    Diez Domingo, Javier
    Redondo Marguello, Esther
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (01) : 1 - 11
  • [29] EVALUATION OF HIGH-DOSE VERSUS STANDARD-DOSE OSELTAMIVIR IN CRITICALLY ILL PATIENTS WITH INFLUENZA
    Kiser, Tyree
    Burnham, Ellen
    Ho, Michael
    Moss, Marc
    Vandivier, R.
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 314 - 314
  • [30] Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
    Niklas Dyrby Johansen
    Daniel Modin
    Joshua Nealon
    Sandrine Samson
    Camille Salamand
    Carsten Schade Larsen
    Brian L. Claggett
    Scott D. Solomon
    Martin J. Landray
    Gunnar H. Gislason
    Lars Køber
    Jens Ulrik Stæhr Jensen
    Pradeesh Sivapalan
    Lasse Skafte Vestergaard
    Palle Valentiner-Branth
    Tyra Grove Krause
    Tor Biering-Sørensen
    Pilot and Feasibility Studies, 8
12345